S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

INKT MiNK Therapeutics Inc

0.9202

0.2233 (32.04%)

After Hours

Last Updated: 17:51:55

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

MiNK Therapeutics (NASDAQ:INKT)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more MiNK Therapeutics Charts.

MiNK Therapeutics (NASDAQ:INKT)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more MiNK Therapeutics Charts.

MiNK Therapeutics Inc News

Form DEF 14A - Other definitive proxy statements
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting
Wednesday 18 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 9 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Monday 9 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Friday 6 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
Monday 11 November 2024 (2 months ago) • GlobeNewswire Inc.

MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 31 October 2024 (2 months ago) • Edgar (US Regulatory)

More MiNK Therapeutics Inc News Articles

Accredited Solutions (PK)

TPT Global Tech (CE)

Quantum eMotion (QB)

RespireRx Pharmaceuticals (CE)

Valiant Eagle (PK)

Fannie Mae (QB)

Anavex Life Sciences

Apple Rush (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions